OABI Q1 2025 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+9.3% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$19M-453.6% margin

Net Income

-$18M-438.1% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-61.6%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$306M

Total Liabilities

$33M

Stockholders' Equity

$274M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+9.3%
Gross Profit	$4M	$4M	+9.3%
Operating Income	-$19M	-$23M	+16.4%
Net Income	-$18M	-$19M	+4.0%

Revenue Segments

Service

$2M91%

Royalty

$188,0009%